Bessemer Group
PRAX icon

Bessemer Group’s Praxis Precision Medicines PRAX Stock Holding History

Bessemer Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25
Closed -$1.56K – 2675
2024
Q4 		$2K Hold
25
– – ﹤0.01% 2255
2024
Q3 		$1K Buy
+25
New +$1.35K ﹤0.01% 2506
2022
Q2 		– Sell
-4
Closed -$1K – 1998
2022
Q1 		$1K Hold
4
– – ﹤0.01% 1785
2021
Q4 		$1K Hold
4
– – ﹤0.01% 1820
2021
Q3 		$1K Hold
4
– – ﹤0.01% 1632
2021
Q2 		$1K Hold
4
– – ﹤0.01% 1552
2021
Q1 		$2K Buy
+4
New +$2.84K ﹤0.01% 1460

Other funds holding PRAX

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bessemer Group's PRAX Position: Q1 2025 in Review

Bessemer Group sold out of Praxis Precision Medicines (PRAX) in Q1 2025, closing a stake of 25 shares — an estimated $1.56K sold.

Bessemer Group first reported a position in PRAX in Q1 2021 and held it in 7 quarters. The position peaked at $2K in Q4 2024. 150 funds tracked by Wall St. Rank hold PRAX as of Q1 2025.

  • Bessemer Group reported no remaining Praxis Precision Medicines position as of Q1 2025 after selling out during the quarter.
  • Bessemer Group sold 25 Praxis Precision Medicines shares in Q1 2025, an estimated $1.56K.
  • Bessemer Group first reported a position in Praxis Precision Medicines in Q1 2021 and held it in 7 quarters.
  • Bessemer Group's Praxis Precision Medicines position peaked at $2K in Q4 2024.
  • 150 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2025.

Based on Bessemer Group's 13F filing for Q1 2025, filed 23 Apr 2025.